Related Experiment Videos

Treatment and prevention of pertussis by antimicrobial agents (Part II)

J E Hoppe1, A Haug

  • 1University Children's Hospital, Tübingen.

Infection
|May 1, 1988
PubMed

Insights

Early antibiotic treatment for whooping cough (pertussis) can shorten the illness. Erythromycin is the preferred antibiotic, though other options like ampicillin and amoxicillin have shown treatment failures.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Whooping cough (pertussis) is a contagious respiratory illness.
  • Antimicrobial therapy during the early stages can impact disease severity.
  • The prophylactic use of antibiotics during pertussis incubation is debated.

Purpose of the Study:

  • To review the efficacy of antimicrobial agents in treating pertussis.
  • To evaluate the role of antibiotics in different stages of whooping cough.
  • To identify optimal antibiotic choices and dosages for pertussis management.

Main Methods:

  • Literature review of existing studies on pertussis treatment.
  • Analysis of clinical data regarding antibiotic efficacy and treatment failures.
  • Comparison of different antimicrobial agents, including erythromycin, ampicillin, amoxicillin, josamycin, and co-trimoxazole.

Main Results:

  • Antimicrobials administered during the catarrhal stage can reduce disease duration.
  • Erythromycin is the current antibiotic of choice for pertussis.
  • Erythromycin estolate showed no treatment failures; high dosages of ethylsuccinate and stearate are needed for respiratory secretions. Ampicillin and amoxicillin have been associated with treatment failures.

Conclusions:

  • Early antimicrobial intervention is beneficial for managing whooping cough.
  • Erythromycin is effective, but specific formulations and dosages are critical.
  • Further research is needed to clarify the roles of josamycin and co-trimoxazole in pertussis treatment.

Related Concept Videos